Try GOLD - Free

Championing a Culture Where Purpose Powers Progress

Fortune US

|

December 2025 - January 2026

Averitas Pharma is making a meaningful difference by putting its people and patients first.

Championing a Culture Where Purpose Powers Progress

AVERITAS PHARMA, A GRÜNENTHAL COMPANY, approaches pain as a disease in urgent need of a solution, not just a symptom to be managed.

Leading with a patient-first mindset, the company is driven by empathy for those living with chronic pain. This powers its purpose of making a difference in the lives of appropriate patients by advancing how pain and its impact are understood and treated.

Based in Morristown, N.J., Averitas has built its reputation on care that extends from science to everyday life. Its culture combines scientific focus with a deep respect for the people who make its mission possible—its employees and the patients it serves.

That commitment continues to earn Averitas recognition as a Great Place To Work

MORE STORIES FROM Fortune US

Fortune US

Fortune US

GET READY TO OWN A TOKENIZED PORTFOLIO

A BLOCKCHAIN \"FREIGHT TRAIN\" IS ALREADY REMAKING WALL STREET'S FINANCIAL PLUMBING. IT COULD MAKE TRADING EVEN FASTER AND CHEAPER

time to read

6 mins

December 2025 - January 2026

Fortune US

RESOURCES HOW RARE EARTHS BECAME GROUND ZERO IN THE U.S.-CHINA RIVALRY

THE WATERSHED moment came in July when the federal government became the largest shareholder of MP Materials, a California miner of rare earth elements.

time to read

2 mins

December 2025 - January 2026

Fortune US

Fortune US

PASSIONS A BLISSFUL ESCAPE FROM DECISION FATIGUE

THE TASTING MENU at Uberto ends, like many others at restaurants of this caliber, with mignardises.

time to read

4 mins

December 2025 - January 2026

Fortune US

Fortune US

JAMIE DIMON OF JPMORGAN CHASE ON STEERING AMERICA'S BIGGEST BANK THROUGH 'INFLATIONARY' TIMES

CEO JAMIE DIMON has led JPMorgan Chase through periods of rapid change and epic turmoil—and Jan. 1, 2026, will be his 20th anniversary in the role.

time to read

6 mins

December 2025 - January 2026

Fortune US

Fortune US

WHAT TO BUY, AND NOT BUY, IN 2026

THREE YEARS OF EUPHORIA IN STOCKS AND OTHER ASSETS HAVE INVESTORS BRACING FOR TROUBLE. HERE'S WHAT TO DO IF BAD NEWS ARRIVES.

time to read

7 mins

December 2025 - January 2026

Fortune US

Fortune US

Breaking the Mold

The Trade Desk's Al-powered platform and open-web ethos has propelled it onto the S&P 500.

time to read

2 mins

December 2025 - January 2026

Fortune US

Fortune US

WINE TARIFF THREATS AND GEN Z SOBRIETY HAVE PUT BORDEAUX ON RED ALERT

IN THE TASTING room of a Bordeaux winery, a photo on the wall shows a pastoral tableau: three generations of the Dubois family, sipping wine on the patio of their Les Bertrands château, with their Australian shepherd, Namek, perched at their feet.

time to read

6 mins

December 2025 - January 2026

Fortune US

Fortune US

HOW AN AI BUBBLE COULD RUIN THE PARTY

IF AI REVENUE DOESN'T CATCH UP WITH AI SPENDING, GLOBAL STOCKS WILL BE AT RISK.

time to read

6 mins

December 2025 - January 2026

Fortune US

Fortune US

INNOVATION IS THE ERA OF ROBOT-DRIVEN UNEMPLOYMENT ALMOST UPON US?

AT A PRESS EVENT LAST YEAR, Amazon Robotics chief technologist Tye Brady told Fortune that the idea that there's a battle of robots versus humans inside Amazon's warehouse network is a “myth.”

time to read

5 mins

December 2025 - January 2026

Fortune US

Fortune US

Nvidia is invincible. Unless it isn't.

The doubters are coming for the world's most valuable company.

time to read

11 mins

December 2025 - January 2026

Listen

Translate

Share

-
+

Change font size